SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 119 filers reported holding SUTRO BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $48,237 | -95.6% | 16,463 | -91.5% | 0.00% | -100.0% |
Q1 2024 | $1,094,241 | +235.1% | 193,671 | +154.4% | 0.01% | +200.0% |
Q4 2023 | $326,581 | +325.2% | 76,126 | +360.9% | 0.00% | +100.0% |
Q2 2023 | $76,804 | -87.5% | 16,517 | -87.6% | 0.00% | -75.0% |
Q1 2023 | $613,677 | -11.1% | 132,830 | +55.6% | 0.00% | 0.0% |
Q4 2022 | $689,951 | -63.8% | 85,390 | -75.1% | 0.00% | -63.6% |
Q3 2022 | $1,906,000 | +46.1% | 343,384 | +37.1% | 0.01% | +37.5% |
Q2 2022 | $1,305,000 | +85.6% | 250,389 | +192.6% | 0.01% | +33.3% |
Q1 2022 | $703,000 | +576.0% | 85,570 | +1452.1% | 0.01% | +500.0% |
Q3 2021 | $104,000 | -80.4% | 5,513 | -80.7% | 0.00% | -83.3% |
Q2 2021 | $530,000 | -40.5% | 28,500 | -27.2% | 0.01% | -45.5% |
Q1 2021 | $891,000 | +148.9% | 39,160 | +137.4% | 0.01% | +120.0% |
Q4 2020 | $358,000 | +247.6% | 16,497 | +61.3% | 0.01% | +150.0% |
Q3 2020 | $103,000 | +2475.0% | 10,229 | +1815.5% | 0.00% | – |
Q2 2020 | $4,000 | -63.6% | 534 | -44.5% | 0.00% | – |
Q2 2019 | $11,000 | – | 962 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |